HIPEC in Ovarian Carcinoma Clinical Stage IIIC and IV During Interval Laparotomy

PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

September 2, 2017

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2026

Conditions
HPECOvarian CancerWomen's Health: Neoplasm of OvaryChemotherapy Effect
Interventions
PROCEDURE

HIPEC

Following complete cytoreductive surgery without any evidence of residual disease, the patient will be randomized either HIPEC (intervention) or no-HIPEC (control) in the operative Room. If the arm HIPEC is obtained, then a HIPEC procedure with cisplatin and doxorubicin will be performed. If no-HIPEC (control arm) is assigned then the surgical procedure will be finished.

Trial Locations (1)

14080

RECRUITING

National Cancer Institute of Mexico, Mexico City

All Listed Sponsors
lead

Instituto Nacional de Cancerologia de Mexico

OTHER